MTAC — Shareholder Vote
MedTech Acquisition Corporation · 2026-05-14
The proposal to approve, on an advisory basis, the compensation of the Company’s named executive officers was approved by the stockholder vote:
Vote type
other
Outcome
passed
Shares for
32,625,082
Shares against
1,206,105
Data sourced from SEC EDGAR filings. Dates reflect the vote/event date as disclosed in the filing. Outcomes updated when follow-up filings are published.